A new coalition of biotechnology stakeholders has formed to promote development of new antibiotics to fight antimicrobial resistance.
The Centers for Disease Control and Prevention estimates more than 2 million Americans experience a drug-resistant infection annually, with at least 23,000 deaths. A new estimate from the Washington University School of Medicine in St. Louis puts the annual death toll as high as 162,000…
More from HealthLeaders here.
Antibiotics cannot cure COVID. They don’t help a bit. And yet, new data shows that, during the pandemic, COVID patients…
Read MoreThe push for antibiotics to fight fast-evolving superbugs is snagging on a broken business model. Six startups have won Food and Drug…
Read MoreThe recent reintroduction of the Pasteur Bill seeks to address the global threat that antimicrobial-resistant (AMR) infections pose, one subscription…
Read MoreDeveloping a new antibiotic can take as long as 15 years. But in as few as two, the target bug…
Read More